News Lilly’s RA drug Olumiant gains first approval in Europe Oral treatment could take the lead among next generation RA drugs
News Sanofi's Kevzara gains first approval in Canada Sanofi and Regeneron's new rheumatoid arthritis (RA) drug Kevzara has gained its first global approval in Canada.
News Delinia adds to Celgene's immunology ambitions Celgene continues with focus on autoimmune diseases.
News Amgen's Humira biosimilar first to gain EU nod But patents could delay launch for more than a year.
News Boehringer transfers schizophrenia DTx selling rights to Cli... Boehringer has altered the terms of its digital therapeutic alliance with Click on schizophrenia app CT-155, taking a more strategic investor role.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
